3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
51
Neoplasms
34
Colorectal Neoplasms
23
Lung Neoplasms
17
Prostatic Neoplasms
16
Melanoma
15
Neoplastic Cells, Circulating
13
Pancreatic Neoplasms
11
Multiple Myeloma
11
Uterine Cervical Neoplasms
10
Ovarian Neoplasms
10
Carcinoma, Non-Small-Cell Lung
8
Papillomavirus Infections
7
Neoplasm Metastasis
7
Leukemia, Myeloid, Acute
7
Colonic Neoplasms
7
Lymphoma, Follicular
6
Lymphoma
6
Hematologic Neoplasms
6
Uveal Melanoma
5
Sarcoma
5
Head and Neck Neoplasms
5
Glioma
5
Uterine Cervical Dysplasia
4
Urinary Bladder Neoplasms
4
Rectal Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Glioblastoma
4
Disease
4
COVID-19
4
Interventions
pembrolizumab
2
Imatinib Mesylate
2
Cisplatin
2
Axitinib
2
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
2
tislelizumab
1
regorafenib
1
gallium 68 PSMA-11
1
avelumab
1
Tretinoin
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sunitinib
1
Radiation
1
Quality of Life
1
Patient Reported Outcome Measures
1
Nelfinavir
1
Molecular Diagnostic Techniques
1
Magnetic Resonance Spectroscopy
1
Immunotherapy
1
GSK-3326595
1
Everolimus
1
Etoposide
1
Endoscopic Mucosal Resection
1
Drug Therapy
1
Doxorubicin
1
Cyclophosphamide
1
Bortezomib
1
Blood Specimen Collection
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Adenoid Cystic
×
Blood Specimen Collection
×
Clear all
NCT01046487
2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1
Completed
26 enrolled